Proven efficacy in both laboratory studies and real-world settings

ActivePure® is the technology proven to reduce pathogens in the air and on surfaces in real-time.

Devices with ActivePure Technology have been proven against a wide-range of pathogens

SARS-CoV-2 (virus)

Staphylococcus aureus (Gram+ bacteria)

Aspergillus niger (endospore; Toxic Black surrogate)

H1N1 (Swine Flu; Influenza A virus)

H5N8 (Bird Flu; Influenza A virus)

Methicillin-Resistant Staphylococcus aureus (MRSA; Gram+ bacteria)

Bacillus globigii (bacterial endospore; Anthrax surrogate)

MS2 (RNA bacteriophage virus)

Staphylococcus epidermis (Gram+ bacteria)

Phi-X174 (DNA bacteriophage virus)

Erwinia herbicola (Gram- bacteria)

Listeria monocytogenes (Gram+ bacteria)

Murine Norovirus (virus)

Escherichia coli (E. coli; Gram- bacteria)

See full list

Hide

ActivePure Medical Guardian testing for FDA Class II Clearance

Pathogen reduction chart showing >99.99% removal of RNA & DNA Viruses, Gram-positive & Gram-negative bacteria, and Fungal & Bacterial mold reduction.

60-Minute average pathogen reduction percent

Graph showing decrease in RNA and DNA virus of 99.9999% and 99.993% respectively in 60 minutes of using ActivePure air purification.

Testing done at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. RNA Virus: MS2 Bacteriophage. DNA Virus: Phi-X174 Bacteriophage.

60-Minute average pathogen reduction percent

Graph showing reduction in gram positive and negative bacteria of 99.999% within 60 minutes of using ActivePure air purification.

Testing done at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Gram-positive Bacteria: Staphylococcus Epidermidis. Gram-negative Bacteria: Erwinia Herbicola.

60-Minute average pathogen reduction percent

Graph showing a 99.99% reduction in Fungal and Bacterial mold 60 minutes after installing ActivePure air purification products.

Testing done at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Fungal Mold: Apergillus Niger. Bacterial Mold: Bacillus Globigii.

Testing done at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. RNA Virus: MS2 Bacteriophage. DNA Virus: Phi-X174 Bacteriophage. Gram-positive Bacteria: Staphylococcus epidermidis. Gram-negative Bacteria: Erwinia herbicola. Fungal Mold: Aspergillus niger. Bacterial Mold: Bacillus globigii.

ActivePure® Technology is scientifically proven to be ≥ 99.9% effective against:

ActivePure Cube Pattern Design Element
ActivePure Cube Pattern Design Element
Hierarchy of pathogens pyramid, Enveloped viruses are at the bottom with the easiest resistance level, then moving to the top with harder resistance in order are bacteria, fungi, non-enveloped viruses, mycobacteria, and spores.

To learn more about the hierarchy of pathogens, review Dr. William Rutala’s Overview of Current Disinfection Hierarchy Models.

Spores

Bacillus Globigii (Spore)

(Same category as Clostridioides Difficile)

Mycobacteria

Testing completed against harder pathogens

(Category of Mycobacterium Tuberculosis)

Non-Enveloped Viruses

MS2 & Phi-X 174 (Non-Enveloped Viruses)

(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])

Fungi

Aspergillus Niger (Fungi)

(Same category as Candida Auris & Trichophyten)

Bacteria

Staphylococcus Epidermis & Erwinia Herbicola (Bacteria) (Same category as MRSA, VRE & Acinetobacter)

Enveloped Viruses

Testing completed against harder pathogens

(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)

Spores

Bacillus Globigii (Spore)

(Same category as Clostridiodes Difficile)

Mycobacteria

Testing completed against harder pathogens

(Category of Mycobacterium Tuberculosis)

Non-Enveloped Viruses

MS2 & Phi-X 174 (Non-Enveloped Viruses)

(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])

Fungi

Aspergillus Niger (Fungi)

(Same category as Candida Auris & Trichophyten)

Bacteria

Staphylococcus Epidermis & Erwinia Herbicola (Bacteria)

(Same category as MRSA, VRE & Acinetobacter)

Enveloped Viruses

Testing completed against harder pathogens

(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)

Hierarchy of pathogens pyramid, Enveloped viruses are at the bottom with the easiest resistance level, then moving to the top with harder resistance in order are bacteria, fun

To learn more about the hierarchy of pathogens, review Dr. William Rutala’s Overview of Current Disinfection Hierarchy Models.

Spores

Bacillus Globigii (Spore)

(Same category as Clostridioides Difficile)

Mycobacteria

Testing completed against harder pathogens

(Category of Mycobacterium Tuberculosis)

Non-Enveloped Viruses

MS2 & Phi-X 174 (Non-Enveloped Viruses)

(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])

Fungi

Aspergillus Niger (Fungi)

(Same category as Candida Auris & Trichophyten)

Bacteria

Staphylococcus Epidermis & Erwinia Herbicola (Bacteria)

(Same category as MRSA, VRE & Acinetobacter)

Enveloped Viruses

Testing completed against harder pathogens

(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)

Spores

Bacillus Globigii (Spore)

(Same category as Clostridiodes Difficile)

Mycobacteria

Testing completed against harder pathogens

(Category of Mycobacterium Tuberculosis)

Non-Enveloped Viruses

MS2 & Phi-X 174 (Non-Enveloped Viruses)

(Same category as Norovirus, Polio & HAV [Hepatitis A Virus])

Fungi

Aspergillus Niger (Fungi)

(Same category as Candida Auris & Trichophyten)

Bacteria

Staphylococcus Epidermis & Erwinia Herbicola (Bacteria)

(Same category as MRSA, VRE & Acinetobacter)

Enveloped Viruses

Testing completed against harder pathogens

(Category of H1N1 [Swine Flu] H5N8 [Bird Flu] & SARS-CoV-2)

Peer-reviewed science

ActivePure is committed to the highest scientific standards, with multiple peer-reviewed studies in progress. Our first study on health care associated infection (HAI) reduction has recently been published in the American Journal of Infection Control. This study is on the pioneering edge of demonstrating that continuous decontamination can reduce surface, floor, and air contamination and thereby reduce the acquisition of HAIs.

Learn More